You are here

Article Text

Article menu
Download PDFPDF
PostScript
Featured correspondence
Advantages of QRISK2 (2010): the key issue is ethnicity and extent of reallocation
  1. Julia Hippisley-Cox1,
  2. Carol Coupland1,
  3. John Robson2,
  4. Peter Brindle3
  1. 1Division of Primary Care, University of Nottingham, University Park, Nottingham, UK
  2. 2Division of Primary Care, Queen Marys, London, UK
  3. 3NHS Bristol, Bristol, UK
  1. Correspondence to Julia Hippisley-Cox, Division of Primary Care, University of Nottingham, 13th Floor Tower Building, University Park, Nottingham NG2 7RD, UK; julia.hippisley-cox{at}nottingham.ac.uk

https://doi.org/10.1136/hrt.2010.221085

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    To the Editor In their paper published in this issue of Heart (see page 491), de la Iglesia et al1 describe the performance of ASSIGN and Framingham algorithms in comparison to the original QRISK equations.

    Readers may be interested that the QRISK2 algorithm was published in February 20092 and made available as free open source software in April 2010.3 This can be found at http://svn.clinrisk.co.uk/opensource/qrisk2/. The open source is intended to further increase the reliable and widespread implementation of QRISK2 into clinical practice.

    There are substantial differences between the original QRISK4 and QRISK25 algorithms which include additional predictor variables together with their associated significant age interactions:

    • —self-assigned ethnicity

    • —rheumatoid arthritis

    • —chronic renal disease

    • —atrial fibrillation.

    All these are independent predictors and improve risk estimates in individual patients. Both QRISK and QRISK2 have been independently validated on …

    View Full Text

    Footnotes

    • Linked article 221093.

    • Competing interests JH-C is professor of clinical epidemiology at the University of Nottingham and co-director of QResearch®—a not-for-profit organisation which is a joint partnership between the University of Nottingham and EMIS (a leading commercial supplier of IT for 60% of general practices in the UK). JH-C is also director of ClinRisk Ltd which produces open and closed source software to ensure the reliable and updatable implementation of clinical risk algorithms within clinical computer systems to help improve patient care. CC is associate professor of medical statistics at the University of Nottingham and a consultant statistician for ClinRisk Ltd. JR and PB have received no financial support for undertaking this work. JR and PB were previously members of the NICE Guideline Development Group for Lipid Modification of which JR was chair. This work and any views expressed within it are solely those of the co-authors and not of any affiliated bodies or organisations. There are no other relationships or activities that could appear to have influenced the submitted work.

    • Provenance and peer review Not commissioned; not externally peer reviewed.

    Linked Articles